,10 This method results in DCIS lesions retaining the sample-specific estrogen receptor (ER), progesterone receptor (PR), and HER2 expression, and can be used to follow the progression of DCIS lesions over time.8 Here, ERBB2 is linked to ductal breast carcinoma in situ.